In order to facilitate the pharma companies, the Drug Controller General of India (DCGI) is setting up sub zonal offices in Chandigarh, Jammu (Jammu & Kashmir) and Bangalore by the end of this year.
Besides, it has also plans to set up sub zonal offices in Guwahati, Goa and Indore next year. The facility will look after facilitation of inspections, issuing of licences, approvals and eventually managing clinical trial audits and would benefit the pharma players.”
The Chandigarh sub zonal office would be fully operational by the end of this year including the laboratory. The move by the centre is likely to benefit over 500 units located in tax free zone of Himachal Pradesh, besides Punjab, some parts of Jammu & Kashmir and Haryana, as they can get clearances and approval locally.